REQUEST A DEMO
Total
USD $0.00
Search more companies

Geneplanet d.o.o. (Croatia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Geneplanet d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Geneplanet d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on July 23, 2026. 14 (2025) employees currently work for Geneplanet d.o.o.. The company’s latest financial report indicates a net sales revenue increase of 35.29% in 2025. There was a total growth of 73.13% in Geneplanet d.o.o.’s total assets over the same period. The net profit margin of Geneplanet d.o.o. increased by 18.06% in 2025.

Headquarters
Horvatova 80A Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Geneplanet d.o.o. report to view the information.

Website: http://www.geneplanet.com

Basic Information
Total Employees:
Purchase the Geneplanet d.o.o. report to view the information.
Financial Auditors:
Purchase the Geneplanet d.o.o. report to view the information.
Incorporation Date:
July 23, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Geneplanet d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
35.29%
Total Operating Revenue
35.29%
Operating Profit
305.86%
EBITDA
173.94%
Net Profit/Loss for the Period
558.11%
Total Assets
73.13%
Total Equity
346.96%
Operating Profit Margin
13.41%
Net Profit Margin
18.06%
Return on Equity (ROE)
32.06%
Debt / Equity
-335.66%
Quick Ratio
-0.23%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?